Even with more restrictive assumptions, the analysis still showed a substantial treatment gap, with only 14.2% of patients ...

Colistin is a polymyxin antibiotic used as a last-resort treatment for severe infections caused by multidrug-resistant Gram-negative bacteria such as Escherichia coli and Pseudomonas aeruginosa. Due ...

Scientists warn that deadly pathogens can survive in this popular home appliance. This research highlights a serious health ...

In a small study, CF patients treated with the therapy saw a reduction in multidrug-resistant lung bacteria and improved lung ...

In this retrospective cohort study, the incidence of hospital-onset antimicrobial resistant infections was found to have ...

A study published in Frontiers explores the microbial diversity within hospital sink drains across multiple wards over a year ...

Some strains of Neisseria gonorrhoeae, the bacteria that causes the sexually transmitted infection (STI) gonorrhea, have ...

Researchers have made a breakthrough discovery that could potentially revolutionize treatments for antibiotic-resistant infections, cancer and other challenging gram-negative pathogens without relying ...

Researchers at the University of Oklahoma have made a breakthrough discovery that could potentially revolutionize treatments for antibiotic-resistant ...

Researchers at the University of Oklahoma have made a discovery that could potentially revolutionize treatments for ...

2) To phenotypically characterize multi-drug-resistant Gram-negative bacteria such as Escherichia coli, Klebsiella pneumoniae, proteus species, Citrobacter species, Salmonella and Shigella isolated ...